PARTELLI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 8.156
AS - Asia 7.548
NA - Nord America 6.824
SA - Sud America 1.532
Continente sconosciuto - Info sul continente non disponibili 455
AF - Africa 145
OC - Oceania 18
Totale 24.678
Nazione #
US - Stati Uniti d'America 6.445
RU - Federazione Russa 4.584
SG - Singapore 2.583
CN - Cina 2.322
BR - Brasile 1.241
IT - Italia 982
HK - Hong Kong 912
SE - Svezia 790
VN - Vietnam 669
BD - Bangladesh 401
DE - Germania 353
FR - Francia 335
RO - Romania 267
GB - Regno Unito 250
IN - India 196
CA - Canada 194
FI - Finlandia 168
AR - Argentina 117
MX - Messico 92
ES - Italia 75
JP - Giappone 72
PL - Polonia 71
AT - Austria 61
ID - Indonesia 61
ZA - Sudafrica 56
IE - Irlanda 54
NL - Olanda 54
TR - Turchia 47
EC - Ecuador 43
CO - Colombia 40
IQ - Iraq 39
PK - Pakistan 31
NP - Nepal 27
PH - Filippine 25
VE - Venezuela 25
MY - Malesia 23
LT - Lituania 21
PY - Paraguay 21
UA - Ucraina 20
UZ - Uzbekistan 19
CL - Cile 18
CR - Costa Rica 18
MA - Marocco 18
JM - Giamaica 16
EG - Egitto 15
AU - Australia 14
DZ - Algeria 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
KE - Kenya 12
TN - Tunisia 12
PE - Perù 11
BE - Belgio 10
HN - Honduras 9
IL - Israele 9
IR - Iran 9
JO - Giordania 9
KZ - Kazakistan 9
NI - Nicaragua 9
UY - Uruguay 9
BH - Bahrain 8
CH - Svizzera 8
MD - Moldavia 8
RS - Serbia 8
PT - Portogallo 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
KR - Corea 6
PA - Panama 6
SV - El Salvador 6
TW - Taiwan 6
AL - Albania 5
GR - Grecia 5
GT - Guatemala 5
OM - Oman 5
PS - Palestinian Territory 5
TH - Thailandia 5
CZ - Repubblica Ceca 4
GE - Georgia 4
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
LB - Libano 3
PR - Porto Rico 3
AM - Armenia 2
AW - Aruba 2
BB - Barbados 2
BZ - Belize 2
CY - Cipro 2
DK - Danimarca 2
EU - Europa 2
HU - Ungheria 2
KG - Kirghizistan 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
Totale 24.201
Città #
Singapore 1.248
Moscow 956
Ashburn 940
Dallas 937
Hong Kong 894
San Jose 697
Council Bluffs 423
Shanghai 392
Beijing 349
New York 317
Hefei 305
Milan 279
Lauterbourg 252
Ho Chi Minh City 223
Los Angeles 223
Lawrence 197
Princeton 194
Santa Clara 156
Hanoi 141
São Paulo 136
Boardman 108
Munich 100
Helsinki 89
Orem 88
London 86
Nuremberg 78
Rome 78
Montreal 62
Chennai 60
Tokyo 55
Dublin 54
Warsaw 54
Chicago 52
Rio de Janeiro 51
Brooklyn 50
Denver 49
Turku 49
Atlanta 47
Frankfurt am Main 46
Phoenix 44
Poplar 44
Omaha 41
The Dalles 41
Guangzhou 37
Manchester 37
Toronto 37
Boston 36
Johannesburg 35
Stockholm 35
Mexico City 34
Buffalo 33
Washington 33
Columbus 30
Seattle 28
Belo Horizonte 27
Haiphong 27
Houston 27
Lappeenranta 27
Mumbai 27
Pune 27
Vienna 27
Da Nang 26
San Francisco 26
Brasília 23
Shenzhen 22
Dhaka 21
Ankara 20
Cesano Boscone 20
Naples 20
Biên Hòa 19
Turin 19
Amsterdam 18
Charlotte 18
Tianjin 18
San José 17
Tashkent 17
Bologna 16
Campinas 16
Falkenstein 16
Thái Bình 16
Florence 15
Miami 15
New Delhi 15
Madrid 14
Baghdad 13
Cape Town 13
Changsha 13
Hải Dương 13
Kuala Lumpur 13
Ottawa 13
Porto Alegre 13
Ribeirão Preto 13
Asunción 12
Barnet 12
Bắc Ninh 12
Las Vegas 12
Memphis 12
Quito 12
Dalian 11
Guayaquil 11
Totale 11.874
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 363
Impact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis 218
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 202
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 199
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 188
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 188
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 187
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 181
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 175
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 165
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 161
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 156
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 152
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 148
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 145
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 139
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 139
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 133
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 132
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 132
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 129
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 128
The impact of preoperative anemia on pancreatic resection outcomes 127
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 127
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 123
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 123
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 122
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 122
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 121
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 120
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 119
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 118
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors 118
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy after Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients 117
The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis 117
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 117
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 116
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 116
Before sentinel bleeding: early prediction of postpancreatectomy hemorrhage (PPH) with a CT-based scoring system 116
Development of a predictive model for unplanned intensive care unit admission after pancreatic resection within an enhanced recovery pathway 115
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 115
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 114
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 114
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 112
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 111
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 111
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 111
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 111
Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study 111
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 110
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 110
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 110
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 110
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 110
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 109
Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 108
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 107
A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine Tumors 107
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 106
Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer 106
The impact of minimally invasive surgery on hospital readmissions, emergency department visits and functional recovery after distal pancreatectomy 106
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 105
Impact of care pathway adherence on recovery following distal pancreatectomy within an enhanced recovery program 105
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 104
Management of clinically relevant postoperative pancreatic fistula-related fluid collections after distal pancreatectomy 104
A systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein 104
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 103
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 103
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 103
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours 103
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 102
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 102
Critical appraisal of the adequacy of surgical indications for non-functioning pancreatic neuroendocrine tumours 102
Either High or Low Risk: The Acinar Score at the Resection Margin Dichotomizes the Risk Spectrum of Pancreas-specific Complications After Pancreatoduodenectomy 101
Non functional pancreatic neuroendocrine tumors 101
A systematic review and meta-analysis on the role of omental or falciform ligament wrapping during pancreaticoduodenectomy 101
How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery 100
ASO Visual Abstract: Detecting Somatic Mutations for Well-Differentiated Pancreatic Neuroendocrine Tumors in Endoscopic Ultrasound-Guided Fine Needle Aspiration with Next-Generation Sequencing 100
Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3 100
Validation of the PROMIS-29 Questionnaire as a Measure of Recovery After Pancreatic Surgery 99
Diagnostic work-up and surgical management of insulinoma: A retrospective analysis from a tertiary referral center 98
Total Pancreatectomy with islet Autotransplantation as an Alternative to high-risk Pancreatojejunostomy after Pancreaticoduodenectomy: A Prospective Randomized Trial 98
Adequacy of lymph node retrieval for ampullary cancer and its association with improved staging and survival 97
Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: Limitations to apply guidelines into real life 97
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Pancreatic Cancer 97
Evaluation of cost-effectiveness among open, laparoscopic and robotic distal pancreatectomy: A systematic review and meta-analysis 96
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 96
Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy 95
Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians 95
Single snapshot imaging of optical properties (SSOP) for perfusion assessment during gastric conduit creation for esophagectomy: An experimental study on pigs 94
Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge 93
New Surgical Strategies 93
Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma 93
Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy 92
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a “Biological R2 Definition” 92
Effects Of Glucocorticoids On B Cell Subpopulations In Patients With IgG4-Related type I autoimmune pancreatitis 91
Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens 90
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 90
Islet autotransplantation in focal intraductal papillary mucinous neoplasms: Evaluating feasibility, safety, and metabolic outcomes in pancreatic resection 90
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 90
Totale 12.042
Categoria #
all - tutte 136.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022119 0 2 7 53 5 5 7 4 10 9 4 13
2022/20231.396 449 281 91 29 23 193 96 106 76 17 14 21
2023/20241.177 24 68 126 128 116 242 27 115 19 34 77 201
2024/20254.666 488 118 128 148 166 406 944 382 692 482 303 409
2025/202615.853 1.008 1.082 1.080 2.120 1.175 550 1.305 1.154 4.153 874 690 662
2026/20271.366 635 731 0 0 0 0 0 0 0 0 0 0
Totale 24.678